In the last two years, the CoEHAR Replica project confirmed the results obtained from the major international studies. It also validated with additional techniques their outcomes under independent conditions.
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
2022 SRNT Annual Meeting - Baltimora Poster Presentation Giovanni Li Volti and Massimo Caruso "E-CIGS EXHIBIT LOWER TOXICITY COMPARED TO CIGARETTES: THE REPLICA STUDY GROUP EXPERIENCE" "COMPARISON OF DIFFERENT CYTOTOXICITY…
These are the professors: Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Sandro La Vignera, Venerando Rapisarda.
Tuesday 16 November at 14.00 CET a seminar on "Living systematic review: a new standard for medical research questions" will be held online on the ZOOM Platform direct by dr. Renèe O'Leary,…
The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.
According to Giovanni Li Volti, director of CoEHAR, the Center of Excellence for the Acceleration of Harm Reduction in Catania, "To date, the results that have emerged confirm that there are no longer any doubts: electronic cigarettes are more than 95% less harmful than conventional cigarettes”
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.